Pembrolizumab-induced rash in a patient with angiosarcoma

• Justin Qian, BA,
• Shelby L. Kubicki, MD,
• Jonathan L. Curry, MD,
• Richard Jahan-Tigh, MD,
• Robert Benjamin, MD,
• Meghan Heberton, MD,
• Kelly C. Nelson, MD

Affiliations

Justin Qian, BA

Baylor College of Medicine School of Medicine, Baylor College of Medicine, Houston, Texas

Shelby L. Kubicki, MD

Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Jonathan L. Curry, MD

Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Richard Jahan-Tigh, MD

Department of Dermatology, University of Texas Health Science Center at Houston, Houston, Texas

Robert Benjamin, MD

Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Meghan Heberton, MD

Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Kelly C. Nelson, MD

Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Correspondence to: Kelly C. Nelson, MD, Department of Dermatology, 1515 Holcombe Blvd Faculty Center Tower, Floor 11, Box 1452, Houston, TX 77030.